The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
PPARγ is an E3 ligase that induces the degradation of NFκB/p65
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
RING Domain E3 Ubiquitin Ligases
Deshaies, R. J., & Joazeiro, C. A. P. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.101807.093809 · Cited by 2,679
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249
Xu, P., Duong, D. M., Seyfried, N. T., Cheng, D., Xie, Y., Robert, J., Rush, J., Hochstrasser, M., Finley, D., & Peng, J. (2009) · Cell · doi:10.1016/j.cell.2009.01.041 · Cited by 1,136
Polyubiquitin chains: polymeric protein signals
Pickart, C. M., & Fushman, D. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.09.009 · Cited by 1,049
Kelly, D., Campbell, J. I., King, T. P., Grant, G., Jansson, E. A., Coutts, A. G. P., Pettersson, S., & Conway, S. (2004) · Nature Immunology · doi:10.1038/ni1018 · Cited by 1,003
Series Introduction: The transcription factor NF-κB and human disease
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11891 · Cited by 990
Ryo, A., Suizu, F., Yoshida, Y., Perrem, K., Liou, Y.-C., Wulf, G., Rottapel, R., Yamaoka, S., & Lu, K. P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00490-8 · Cited by 637
Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms
Straus, D. S., & Glass, C. K. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.09.003 · Cited by 554
Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer
Sarraf, P., Mueller, E., Smith, W. M., Wright, H. M., Kum, J. B., Aaltonen, L. A., de la Chapelle, A., Spiegelman, B. M., & Eng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(01)80012-5 · Cited by 506
Substrate Targeting in the Ubiquitin System
Laney, J. D., & Hochstrasser, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80752-7 · Cited by 449
Kim, H. T., Kim, K. P., Lledias, F., Kisselev, A. F., Scaglione, K. M., Skowyra, D., Gygi, S. P., & Goldberg, A. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609659200 · Cited by 438
Bas, A., Forsberg, G., Hammarström, S., & Hammarström, M. ‐. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01440.x · Cited by 434
Mukherjee, R., Jow, L., Croston, G. E., & Paterniti, J. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8071 · Cited by 420
NF-κB in cancer: a marked target
Lin, A., & Karin, M. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00128-1 · Cited by 355
Chung, S. W., Kang, B. Y., Kim, S. H., Pak, Y. K., Cho, D., Trinchieri, G., & Kim, T. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002577200 · Cited by 338
Tanaka, T., Grusby, M. J., & Kaisho, T. (2007) · Nature Immunology · doi:10.1038/ni1464 · Cited by 325
COMMD1 promotes the ubiquitination of NF‐κB subunits through a cullin‐containing ubiquitin ligase
Maine, G. N., Mao, X., Komarck, C. M., & Burstein, E. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601489 · Cited by 278
Saccani, S., Marazzi, I., Beg, A. A., & Natoli, G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040196 · Cited by 253
The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes
Ganesh, L., Burstein, E., Guha-Niyogi, A., Louder, M. K., Mascola, J. R., Klomp, L. W. J., Wijmenga, C., Duckett, C. S., & Nabel, G. J. (2003) · Nature · doi:10.1038/nature02171 · Cited by 226
Shimada, T., Kojima, K., Yoshiura, K., Hiraishi, H., & Terano, A. (2002) · Gut · doi:10.1136/gut.50.5.658 · Cited by 222
Ruan, H., Pownall, H. J., & Lodish, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303141200 · Cited by 185
PPAR-γ receptor ligands: novel therapy for pituitary adenomas
Heaney, A. P., Fernando, M., & Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16575 · Cited by 184
Ogino, S., Shima, K., Baba, Y., Nosho, K., Irahara, N., Kure, S., Chen, L., Toyoda, S., Kirkner, G. J., Wang, Y. L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.048 · Cited by 171
MAPK- Kinases as Nucleo-Cytoplasmic Shuttles for PPARγ
Burgermeister, E., & Seger, R. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4453 · Cited by 138
GCN5 is a required cofactor for a ubiquitin ligase that targets NF-κB/RelAPreprint
Mao, X., Gluck, N., Li, D., Maine, G. N., Li, H., Zaidi, I. W., Repaka, A., Mayo, M. W., & Burstein, E. (2009) · Genes & Development · doi:10.1101/gad.1748409 · Cited by 133
Synergy between PPARγ Ligands and Platinum-Based Drugs in Cancer
Girnun, G. D., Naseri, E., Vafai, S. B., Qu, L., Szwaya, J. D., Bronson, R. T., Alberta, J. A., & Spiegelman, B. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.025 · Cited by 128
Nuclear Ubiquitin Ligases, NF-κB Degradation, and the Control of Inflammation
Natoli, G., & Chiocca, S. (2008) · Science Signaling · doi:10.1126/stke.11pe1 · Cited by 114
Physiological and Therapeutic Roles of Peroxisome Proliferator-Activated Receptors
Berger, J. P., & Wagner, J. A. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/15209150260007381 · Cited by 107
Nuclear factor-κB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells
Gavert, N. S., Ben‐Shmuel, A., Lemmon, V., Brabletz, T., & Ben‐Ze'ev, A. (2010) · Journal of Cell Science · doi:10.1242/jcs.069542 · Cited by 99
Hou, Y., Mortimer, L. M., & Chadee, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066035 · Cited by 93
Self-citationPPARγ1 attenuates cytosol to membrane translocation of PKCα to desensitize monocytes/macrophages
von Knethen, A., Soller, M., Tzieply, N., Weigert, A., Johann, A. M., Jennewein, C., Köhl, R., & Brüne, B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200605038 · Cited by 78
Epithelial NF-κB maintains host gut microflora homeostasis
Ben‐Neriah, Y., & Schmidt‐Supprian, M. (2007) · Nature Immunology · doi:10.1038/ni0507-479 · Cited by 39
Rosiglitazone: a new therapy for Type 2 diabetes
Greene, D. A. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.10.1709 · Cited by 23
Cited by
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019) · Antioxidants · doi:10.3390/antiox9010021 · Cited by 818
NF-κB and the Transcriptional Control of Inflammation
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2017.07.007 · Cited by 498
E3 ubiquitin ligases: styles, structures and functions
Yang, Q., Zhao, J., Chen, D., & Wang, Y. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00043-2 · Cited by 435
Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors
Korbecki, J., Bobiński, R., & Dutka, M. (2019) · Inflammation Research · doi:10.1007/s00011-019-01231-1 · Cited by 415
Fatty acids, eicosanoids and PPAR gamma
Marion-Letellier, R., Savoye, G., & Ghosh, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.004 · Cited by 332
Metadata
- Authors
- Hou, Y., Moreau, F., & Chadee, K.
- Venue
- Nature Communications
- Published
- 2012-12-18
- Volume
- 3
- Issue
- 1
- Pages
- 1300-1300
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2010461435
- Cited by
- 325
- References
- 37
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.